dc.contributor.author |
Kolar, Matthew J. |
en_US |
dc.contributor.author |
KAMAT, SIDDHESH S. |
en_US |
dc.date.accessioned |
2019-04-29T09:25:02Z |
|
dc.date.available |
2019-04-29T09:25:02Z |
|
dc.date.issued |
2016-08 |
en_US |
dc.identifier.citation |
Biochemistry, 55 (33), 4636-4641. |
en_US |
dc.identifier.issn |
Jun-60 |
en_US |
dc.identifier.issn |
1520-4995 |
en_US |
dc.identifier.uri |
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/2645 |
|
dc.identifier.uri |
https://doi.org/10.1021/acs.biochem.6b00565 |
en_US |
dc.description.abstract |
A recently discovered class of endogenous mammalian lipids, branched fatty acid esters of hydroxy fatty acids (FAHFAs), possesses anti-diabetic and anti-inflammatory activities. Here, we identified and validated carboxyl ester lipase (CEL), a pancreatic enzyme hydrolyzing cholesteryl esters and other dietary lipids, as a FAHFA hydrolase. Variants of CEL have been linked to maturity-onset diabetes of the young, type 8 (MODY8), and to chronic pancreatitis. We tested the FAHFA hydrolysis activity of the CEL MODY8 variant and found a modest increase in activity as compared with that of the normal enzyme. Together, the data suggest that CEL might break down dietary FAHFAs. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
American Chemical Society |
en_US |
dc.subject |
Branched Fatty Acid Esters |
en_US |
dc.subject |
Hydroxy Fatty Acids |
en_US |
dc.subject |
MODY8 Protein Carboxyl Ester Lipase |
en_US |
dc.subject |
Transgenic mice overexpressing |
en_US |
dc.subject |
Lipidomic profiling |
en_US |
dc.subject |
2016 |
en_US |
dc.title |
Branched Fatty Acid Esters of Hydroxy Fatty Acids Are Preferred Substrates of the MODY8 Protein Carboxyl Ester Lipase |
en_US |
dc.type |
Article |
en_US |
dc.contributor.department |
Dept. of Biology |
en_US |
dc.identifier.sourcetitle |
Biochemistry |
en_US |
dc.publication.originofpublisher |
Foreign |
en_US |